These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3030781)

  • 1. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat.
    Walker JM; Thompson LA; Frascella J; Friederich MW
    Eur J Pharmacol; 1987 Jan; 134(1):53-9. PubMed ID: 3030781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of the kappa opiate U50,488 in the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Brain Res; 1990 May; 517(1-2):81-7. PubMed ID: 2165438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
    Ignar DM; Kuhn CM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of putative kappa opioid-sensitive cells of the substantia nigra pars reticulata.
    Thompson LA; Walker JM
    Prog Clin Biol Res; 1990; 328():335-8. PubMed ID: 2154790
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
    Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.
    Pumford KM; Russell JA; Leng G
    Exp Brain Res; 1993; 94(2):237-46. PubMed ID: 8395406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mu and kappa opioid modulation of olfactory bulb evoked potentials.
    Pérez H; Hernández A; Inostroza H
    Int J Neurosci; 1989 Dec; 49(3-4):329-32. PubMed ID: 2561634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiatergic modulation of preparatory and consummatory components of feeding and drinking.
    Nencini P; Graziani M
    Pharmacol Biochem Behav; 1990 Nov; 37(3):531-7. PubMed ID: 1965043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of opiates in the rat substantia nigra: an electrophysiological analysis.
    Hommer DW; Pert A
    Peptides; 1983; 4(5):603-8. PubMed ID: 6657509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.